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ABSTRACT During pneumonic plague, the bacterium Yersinia pestis elicits the development of inflammatory lung lesions that
continue to expand throughout infection. This lesion development and persistence are poorly understood. Here, we examine
spatially distinct regions of lung lesions using laser capture microdissection and transcriptome sequencing (RNA-seq) analysis
to identify transcriptional differences between lesion microenvironments. We show that cellular pathways involved in leukocyte
migration and apoptosis are downregulated in the center of lung lesions compared to the periphery. Probing for the bacterial
factor(s) important for the alteration in neutrophil survival, we show both in vitro and in vivo that Y. pestis increases neutrophil
survival in a manner that is dependent on the type III secretion system effector YopM. This research explores the complexity of
spatially distinct host-microbe interactions and emphasizes the importance of cell relevance in assays in order to fully under-
stand Y. pestis virulence.
IMPORTANCE Yersinia pestis is a high-priority pathogen and continues to cause outbreaks worldwide. The ability of Y. pestis to
be transmitted via respiratory droplets and its history of weaponization has led to its classification as a select agent most likely to
be used as a biological weapon. Unrestricted bacterial growth during the initial preinflammatory phase primes patients to be
infectious once disease symptoms begin in the proinflammatory phase, and the rapid disease progression can lead to death be-
fore Y. pestis infection can be diagnosed and treated. Using in vivo analyses and focusing on relevant cell types during pneu-
monic plague infection, we can identify host pathways that may be manipulated to extend the treatment window for pneumonic
plague patients.
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Neutrophils are an important and necessary component of theinnate immune system. During infection, neutrophils are
rapidly called to the site of insult and can quickly activate a myriad
of antimicrobial functions in an attempt to control invading
pathogens (1–4). This rapid antimicrobial response is facilitated
by neutrophil priming from signals initiated by the innate im-
mune system upon detection of a pathogen (5–7). Upon direct
interaction with a secondary stimulus, such as invading microbes,
there is enhancement of the respiratory burst, cytoskeletal rear-
rangements that retain neutrophils in the lung and facilitate
phagocytosis, regulation of neutrophil surface antigens (7–9), and
release of antimicrobial peptides/proteins from granules (10–12).
Inadvertent acute lung injury can occur if the recruited neutro-
phils are not efficiently released from the pulmonary compart-
ment back into circulation or if appropriate neutrophil turnover
and removal do not occur (6, 7, 12). After mounting an antimi-
crobial response, neutrophils typically undergo necrosis, apopto-
sis, or neutrophil extracellular trap formation (NETosis), all of
which ultimately lead to macrophage infiltration and clearance of
dead or dying neutrophils as well as any remaining bacteria (9,
12–18). Pathogenic microbes, however, have evolved ways to
evade activated neutrophils (10, 19, 20), resulting in increased
disease severity and mortality (20, 21). Pathogens have been
shown to utilize various mechanisms to alter neutrophil function,
including inhibiting neutrophil chemotaxis (22–26), preventing
phagocytosis (27–31), altering degranulation (32, 33), and, im-
portantly for this work, inhibiting neutrophil apoptosis (34–38).
Yersinia pestis, the causative agent of plague, is a high-priority
pathogen that poses a severe threat to both human and animal
health and continues to cause modern day outbreaks worldwide
(39, 40). The ability of Y. pestis to be transmitted via respiratory
droplets and its history of weaponization have led to its classifica-
tion as a Tier 1 select agent. Inhalation of the bacterium leads to
the most deadly form of plague disease, known as primary pneu-
monic plague. If antibiotic treatment is not administered within
24 h after the onset of symptoms, the disease approaches 100%
mortality (40).
Despite the recruitment of neutrophils to control Y. pestis in
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the lungs, bacterial numbers continue to increase throughout the
duration of infection (41). The increase in bacterial burden coin-
cides with continued neutrophil recruitment, accumulation in the
lungs, and subsequent targeting of neutrophils by the Y. pestis type
III secretion system (T3SS) (42, 43). The massive neutrophilic
infiltration during pneumonic plague results in the formation of
histopathologically distinct lung lesions that arise during the later
(proinflammatory) phase of disease. These lesions expand in the
lungs as neutrophils continue to accumulate until death of the
host, with no evidence of bacterial or neutrophil clearance (41).
The continued influx of neutrophils and their apparent prolonged
survival are contrary to typical neutrophil function but have also
been observed in neutrophils of cystic fibrosis patients (44). The
continuous neutrophil influx during pneumonic plague results in
alveolar destruction within lung lesions and culminates in a severe
and deadly necrotizing pneumonia (45).
Yersinia pestis is known to inhibit the host immune response
via various virulence mechanisms (10, 46–49). However, it has
just recently been appreciated that the functions of specific T3SS
effectors may vary, depending on the cell type being targeted (50).
Neutrophils are the most prominent immune infiltrate during
pneumonic plague, are selectively targeted by Y. pestis, and are
necessary for development of lung lesions (42). Early recruitment
of neutrophils is also linked to decreased bacterial burden and
increased survival of Y. pestis-infected mice (51). It is necessary to
interrogate this inflammatory environment in the context of neu-
trophils to understand how interactions with Y. pestis determine
pneumonic plague presentation and progression.
In this work, fully virulent Y. pestis was employed along with
the novel use of laser capture microdissection (LCM) and tran-
scriptome sequencing (RNA-seq) technology to evaluate host
transcription within the expanding neutrophil-rich lung lesions
that arise during pneumonic plague. Yersinia pseudotuberculosis
has been shown to regulate genes spatially within infected tissue
(52), and we hypothesized that spatially distinct transcriptional
modulation would also be observable in Y. pestis lung lesions. We
combined global transcriptional analysis in defined lesion mi-
croenvironments with in vitro and in vivo characterization of neu-
trophils that have interacted with Y. pestis. Together, these studies
provide evidence that Y. pestis promotes neutrophil survival and
inhibits apoptosis in a novel T3SS effector-dependent manner.
This work is the first application of LCM to evaluate the effects of
a bacterial pathogen on a host microenvironment during disease-
mediated injury. By determining how Y. pestis alters the neutro-
phil life span and induces unique transcriptional responses within
sites of infection, we will better understand the mechanisms by
which neutrophils typically work in a broad range of diseases in
which neutrophil infiltration becomes harmful to the host.
RESULTS
Characterizing host gene regulation in spatially defined regions
of pneumonic plague lung lesions. Pulmonary infection of mice
with Y. pestis results in the formation of distinct inflammatory
lesions in the lung during the proinflammatory phase of disease.
The lesions consist primarily of Y. pestis bacteria and densely
packed pockets of neutrophils, and these inflamed sites expand
throughout the duration of infection, ultimately covering entire
lobes of the lung (41). At 48 h postinoculation (hpi) with Y. pestis
FIG 1 Lung lesion histology and laser capture microdissection of lesions. Representative H&E-stained sections of a Y. pestis-infected lung at 48 hpi are shown
at different magnifications (A to C) Scale bars equal 500, 50, and 20 m, respectively. (C) The green arrows indicate dense aggregates of Y. pestis. (D and E)
Representative images of a lung section before (D) and after (E) laser capture microdissection. The scale bar equals 300 m. The lung lesion (outlined in black)
was identified, and the periphery and center of the lesions were spatially defined (outlined in white). Laser cutting and pulse catapulting into a preservative resin
selectively removed white-outlined lesion sections.
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strain CO92, we observed that a typical 5-m hematoxylin and
eosin (H&E)-stained lung section sampled centrally through all 5
lung lobes contained up to 5 distinct foci of inflammation per
lobe. Individual inflammatory foci were as large as 3 mm in diam-
eter, with inflammation occupying 5 to 10% of the total examined
tissue plane (Fig. 1A). The inflammatory infiltrate was composed
predominantly of neutrophils, with fewer macrophages within al-
veolar air spaces. Interspersed amid the inflammatory infiltrate
were abundant extracellular bacterial organisms and variable
amounts of fibrin, hemorrhage, edema, and cellular debris. The
majority of large and small bronchi remained unaffected, even
those located immediately adjacent to inflammatory foci. Occa-
sional dense aggregates of extracellular bacteria formed small col-
onies, particularly at the periphery of lesions (Fig. 1C). These ob-
servations suggested that we could learn more quantitative
information from these lesions by spatially dissecting them to an-
alyze unique microenvironments.
To further characterize these inflammatory lung lesions, we
focused on analyzing transcriptional responses in neutrophils to
understand the lack of turnover and clearance of this key cell type.
The T3SS of Y. pestis has potent anti-inflammatory effects on tar-
geted mammalian cells (53). As a result of their direct contact with
Y. pestis, we predicted that those neutrophils found within the
initiating focus of the lung lesions, the lesion “center,” would have
a different transcriptional profile than those found in the lesion
periphery, where we assumed the most recent wave of migrating
neutrophils would be found. To test this, we devised an approach
to identify transcriptionally regulated host pathways in neutro-
phils found within these spatially distinct regions. Briefly, we in-
fected mice with 104 cells of Yersinia pestis CO92, a fully virulent
strain. At 48 hpi, we treated lungs with an RNA preservative and
then used LCM on fixed and frozen sections to collect tissue from
the center and periphery of the lesions (Fig. 1D and E).
Total RNA was isolated from these captured microenviron-
ments, RNA-seq libraries were prepared, and samples were se-
quenced to define the host transcriptional responses. Addition-
ally, we harvested total RNA from magnetically activated cell
sorting (MACS)-isolated neutrophils (polymorphonuclear leuko-
cytes) residing in the bone marrow (BM-PMNs) of Y. pestis-in-
fected and mock-infected mice at 48 hpi for comparison. Using
Student’s t test, 976 genes were identified that were differentially
expressed between the periphery and center of the lung lesions
(P  0.05). This analysis was simultaneously performed on the
FIG 2 Clustered genes showing differential transcription. A heat map shows 224
genes differentially expressed in two comparisons (BM-PMNs from mock-
infected versus infected mice and lesion periphery versus center). The red and
green colors represent an increase or decrease, respectively, relative to the median
value of each of the two initial comparisons. The x-axis clustering shows that all
triplicates clustered together and that mock-infected BM-PMN and lesion center
samples clustered more closely, as did infected BM-PMN and lesion periphery
samples. Each gene shows significant differences (P  0.05 by Student’s t test) in
each of the two initial comparisons. The blue, orange, yellow, and purple bars
represent the four possible outcomes of gene regulation comparisons: e.g., the blue
bar shows genes that were decreased in infected compared to mock-infected BM-
PMNs and increased in the lesion center compared to the periphery.
FIG 3 Density curves of defined gene sets compared to the entire transcriptome. Gene sets were compiled to represent the general cell migration (A), leukocyte
migration (B), and apoptosis (C) pathways. Using the log ratio of RNA-seq reads in the lesion periphery compared to the lesion center, log ratios of each of these
compiled gene sets (blue lines) were contrasted against the entire transcriptome (gray lines) using a Wilcoxon rank-sum test. The y-axis values are arbitrary units
as calculated by Gaussian kernel density estimates. Only genes with 3 reads from the RNA-seq analysis were graphed.
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infected and mock-infected BM-PMN samples. This comparison
identified 3,198 genes that were differentially expressed in BM-
PMNs from infected mice compared to those from mock-infected
mice. Importantly, transcriptionally altered BM-PMN genes rep-
resent neutrophil-specific responses to Y. pestis infection at 48 hpi
and are a heterologous tissue match to the lung lesion samples
collected at the same time point during infection. Matching genes
in the lesion periphery/center comparison to those genes found in
the BM-PMN comparison allowed us to narrow the lung lesion
gene set to those genes regulated specifically in neutrophils rather
than other cell types in the lung. The initial list of 976 genes was
reduced to 224 genes that were differentially expressed in both the
BM-PMN and lung lesion comparisons, with a significant enrich-
ment value of P  0.02 (Fig. 2; see Table S1 in the supplemental
material). This confirms that there are transcriptional alterations
in neutrophil genes between the lesion periphery and center and
establishes that Y. pestis causes a sustained change in neutrophil
transcription at distinct locations in lung lesions. Interestingly,
when the four conditions (infected BM-PMNs, mock-infected
BM-PMNs, lesion periphery, and lesion center) were clustered
across samples, the differential expression patterns of the 224
genes showed that (i) the BM-PMNs from mock-infected mice
and lesion center conditions clustered together, and (ii) the BM-
PMNs from Y. pestis-infected mice and lesion periphery condi-
tions clustered together (Fig. 2). This suggests that the neutrophils
in the lesion center had a transcriptional pattern more similar to
unstimulated bone marrow neutrophils, despite residing in a
highly inflammatory microenvironment in the infected lungs.
Gene set analysis implications for lesion development and
neutrophil fate. Using the Ingenuity Pathway Analysis (IPA) pro-
gram (Qiagen, Redwood City, CA) and the Molecular Signatures
Database (54), we compiled various gene sets (see Table S2 in the
supplemental material) to analyze pathways for differential gene
expression patterns between the lesion periphery and center. Den-
sity curves were generated based on the ratio of RNA expression
estimates between the lesion periphery and lesion center (when
there were more than three reads in both conditions). A Wilcoxon
rank-sum test was performed comparing the log ratio distribution
from the individual gene sets to the entire transcriptome, with the
goal of identifying bias in specific gene sets.
Based on the log ratio of lesion periphery compared to the
center, there was a statistically significant shift for genes in “leu-
kocyte migration” pathways compared to the entire transcrip-
tome (Fig. 3B). This shift indicates relatively lower expression in
the center of lesions: i.e., the lesion centers show an overall down-
regulation of genes in this list. In contrast, “general cell migration”
genes showed no shift in the lesion periphery/center ratio com-
pared to the entire transcriptome (Fig. 3A; see Table S2). These
transcriptional comparisons in the “leukocyte migration” path-
ways suggest that newly infiltrating neutrophils are localized at the
FIG 4 The type III secretion system effector YopM is necessary for enhanced neutrophil survival. Primary human neutrophils were incubated in buffered RPMI
at 37°C and 5% CO2, with or without bacterial inoculation. After 24 h, the remaining “healthy neutrophils” were assayed by flow cytometry (CD16, CD66b,
annexin V, 7-aminoactinomycin D [7-AAD]/PI). (A) After incubation with wild-type Y. pestis, there were significantly more healthy neutrophils than both
uninoculated cells and nonpathogenic E. coli-inoculated cells. (B) After incubation with a pla mutant, there was no difference in healthy neutrophils compared
to inoculation with wild-type Y. pestis. However, inoculation with a pCD1 (T3SS-negative) mutant caused a significant decrease in healthy neutrophils. (C)
Comparing inoculations with six individual T3SS effector mutants, only the yopM mutant significantly decreased the percentage of healthy neutrophils
compared to inoculation with wild-type Y. pestis. (D) Complementation of the yopM strain restored neutrophil survival to the level seen with wild-type Y. pestis.
Results are from representative experiments performed in triplicate. Data are represented as means  standard errors of the means (SEM). Asterisks represent
statistical significance based on Tukey’s multiple comparison tests from an ordinary one-way analysis of variance (ANOVA) (**, P  0.01; ***, P  0.001).
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periphery of the expanding lesions, while the neutrophils at the
center were likely recruited much earlier. The histopathological
evidence in the lungs also supports this scenario. Centrally within
inflammatory foci, neutrophils are densely packed, completely
filling alveolar spaces and leading to loss of the alveolar septa.
Peripherally there are fewer, loosely packed neutrophils with some
remaining clear air space.
We additionally evaluated whether neutrophil apoptosis/sur-
vival was being altered in the center of lung lesions, since this
could explain continued neutrophil accumulation due to lack of
turnover in the lung. A set of genes representing various apoptosis
pathways was compiled (see Table S2 in the supplemental mate-
rial) and showed a statistically significant shift in the lesion pe-
riphery/center ratio compared to the entire transcriptome, indi-
cating a downregulation of genes in the apoptosis pathways in the
lesion center (Fig. 3C).
Yersinia pestis effects on human neutrophil survival in vitro.
Based on pathway analysis of the LCM/RNA-seq data, we wanted
to verify that Y. pestis alters neutrophil death, leading to increased
survival, which may contribute to continued lesion expansion. We
compared the survival of uninoculated primary human neutro-
phils to those of both Y. pestis- and nonpathogenic Escherichia
coli-inoculated neutrophils in vitro. At 24 hpi, neutrophils were
harvested for analysis of apoptotic and dying cells by flow cytom-
etry. An aliquot of cells was also fixed at 0 hpi to retain the initial
starting concentration of neutrophils in each assay. After 24 hpi,
the population of remaining “healthy” (annexin V negative [an-
nexin V], propidium iodide negative [PI]) neutrophils ranged
from 40 to 60% of the initial seeding population, depending on
the donor. Inoculation with nonpathogenic E. coli resulted in sur-
vival of only 20 to 30% of the initial population. In contrast, in-
oculation with Y. pestis resulted in 60 to 80% survival of the initial
population (Fig. 4A), a significant increase in surviving healthy
neutrophils compared to uninoculated or E. coli-inoculated neu-
trophils.
Role of the type III secretion system in increased survival of
human neutrophils. After determining that Y. pestis significantly
increased the survival of neutrophils, we tested if this could be
attributed to a known virulence determinant of Y. pestis. We in-
oculated human neutrophils in vitro with Y. pestis strains lacking
the pigmentation locus (pgm-negative) (data not shown), the
plasminogen activator protease (pla), and the plasmid encoding
the T3SS (pCD1). We observed that neutrophils inoculated with
a pgm-negative or pla mutant showed similar survival to those
inoculated with wild-type Y. pestis, while infection with a pCD1
mutant significantly decreased neutrophil survival (Fig. 4B), indi-
cating that the phenotype is dependent on the T3SS. We next
tested mutants of the six primary T3SS effectors (yopE, yopH,
yopJ, yopM, yopO, and yopT) in the neutrophil assay and
observed that only infection with the yopM mutant showed a
significant decrease in neutrophil survival compared to inocula-
tion with wild-type Y. pestis (Fig. 4C). We also observed that a
yopM/yopM complemented strain reproduced the phenotype of
the wild-type strain (Fig. 4D) and validated our conclusion that
YopM is important in modulating neutrophil survival.
A novel function for YopM in neutrophil survival. YopM is
known to have two intracellular functions: (i) binding ribosomal
S6 kinase (RSK) and protein kinase N1 (PKN) (27), which induces
prolonged activation of RSK (55), and (ii) inhibiting caspase-1
activity and inflammasome formation that leads to pyroptotic cell
death (56, 57). To determine which function of YopM might be
responsible for enhancing neutrophil survival, we performed a
neutrophil infection assay in the presence of inhibitors of these
two functions. To test the effect of continued YopM-induced RSK
activity on neutrophil survival, we used the RSK inhibitor BI-
D1870 (58). Addition of increasing doses of BI-D1870 to neutro-
phils inoculated with wild-type Y. pestis showed no decrease in
neutrophil survival (Fig. 5A), indicating that the prolonged kinase
activity of RSK induced by YopM had no effect on neutrophil
survival. We validated the functionality of BI-D1870 by monitor-
FIG 5 Inhibition of known functions of YopM does not alter neutrophil survival. Primary human neutrophils were incubated with or without bacterial
inoculation and drug treatment. After 24 h, the remaining “healthy neutrophils” were assayed by flow cytometry (CD16, CD66b, annexin V, 7-AAD/PI).
(A) Treatment with the RSK inhibitor BI-D1870 had no effect on the percentage of healthy neutrophils in culture for either uninoculated or wild-type
Y. pestis-inoculated samples. (B) Treatment with the caspase-1 inhibitor Z-YVAD-FMK showed a significant increase in the percentage of healthy neutrophils
compared to untreated samples. However, there was also still a significant difference in the percentage of healthy neutrophils remaining in uninoculated and
yopM mutant-inoculated samples compared to wild-type Y. pestis-inoculated samples. Results are from representative experiments performed in triplicate.
Data are represented as means  SEM. n.s., not significant. Asterisks represent statistical significance based on Tukey’s multiple comparison tests from an
ordinary one-way ANOVA (***, P  0.001).
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ing the phosphorylation of the S6 protein (59) at the highest tested
dose of this RSK inhibitor. Even after 24 h, neutrophils treated
with BI-D1870 showed decreased phosphorylation of S6 (see
Fig. S1 in the supplemental material). We next tested the effect of
inhibiting caspase-1 during inoculation with a yopM mutant,
using the caspase-1 inhibitor Z-YVAD-FMK. In the presence of
this inhibitor, neutrophil survival was not enhanced after inocu-
lation with the yopM mutant compared to survival of uninocu-
lated neutrophils. We did observe an overall increase in neutro-
phil survival in samples treated with Z-YVAD-FMK, though this
was significantly lower than the survival seen during infection
with wild-type Y. pestis. This could indicate that there is a certain
amount of caspase-1-dependent neutrophil death, but this is not
the mechanism through which YopM is acting (Fig. 5B). Addi-
tionally, no significant increase in survival was seen when neutro-
phils inoculated with wild-type Y. pestis were treated with this
caspase-1 inhibitor (data not shown). This could alternatively in-
dicate that the increase in survival seen under the other conditions
is due to the potential cross reactivity of Z-YVAD-FMK with
caspases-4 and -5 and may be more related to apoptosis than py-
roptosis. These findings suggest a novel function of YopM specif-
ically related to neutrophil survival that does not involve its
known functions of RSK and PKN binding or caspase-1 inhibi-
tion.
Role of YopM in the inhibition of apoptosis in lung lesions.
Since YopM is important for prolonging neutrophil survival in
vitro, we tested if YopM is involved in sustaining neutrophil health
within inflammatory lung lesions in vivo. Lungs of mice infected
with wild-type or yopM Y. pestis were collected at 48 hpi and
sectioned for H&E staining. Neither the size nor total number of
inflammatory lesions was significantly altered in the yopM-
infected lungs compared to wild-type infection. The bacterial bur-
dens in the lungs were similar between the two infections by CFU
count assays (Fig. 6A). However, while the overall pattern of pul-
monary inflammation was similar between the two infections
(Fig. 6B and C), the centers of the largest inflammatory foci in the
yopM mutant-infected lungs displayed more prominent necro-
sis of the alveolar septa. We also observed a striking difference in
lung lesion cellular appearance between wild type and yopM
mutant-infected mice (Fig. 6D and E). In the yopM mutant-
infected tissues, increased numbers of neutrophils were degranu-
lated and had faded nuclei. Additionally, amid viable inflamma-
tory cells, there were individual amphophilic cell bodies (3 to
5 m in diameter, round to slightly misshapen) that lacked a dis-
FIG 6 YopM-dependent effects on bacterial burden and histopathology during pulmonary infection with Y. pestis. (A) At 48 hpi, there is no difference in lung
bacterial burdens in mice infected with wild-type or yopM mutant Y. pestis as quantified by CFU. (B and C) On microscopic examination of H&E-stained
tissues, there is no difference in the size or number of lung lesions in mice infected with wild-type or yopM mutant Y. pestis. (D and E) At higher magnification,
however, large numbers of anucleate cell bodies can be seen throughout the lung lesions in mice infected with the yopM mutant (representative cells marked
with blue arrows) that are not present during an infection with wild-type Y. pestis. Scale bars in images represent 200 m (B and C) or 20 m (D and E). CFU data
are represented as geometric means  95% confidence intervals (CI).
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cernible nucleus and often displayed faint stippling (Fig. 6E, blue
arrows). Correspondingly, we observed increased DNA damage
via fluorescent terminal deoxynucleotidyltransferase-mediated
dUTP-biotin nick end labeling (TUNEL) staining in lung lesions
of yopM mutant-infected mice compared to wild-type Y. pestis-
infected mice (Fig. 7). This TUNEL staining is indicative of apo-
ptotic cell death and correlates with the presence of the ampho-
philic cell bodies. These in vivo observations confirm the
importance of YopM-induced neutrophil survival seen in vitro.
Furthermore, these results are consistent with the RNA-seq anal-
ysis suggesting that the cells in the center of lesions have a de-
creased capacity to undergo apoptosis in a wild-type Y. pestis in-
fection, leading to the distinctive lung lesions seen in pneumonic
plague.
DISCUSSION
Despite previous research on interactions between neutrophils
and Y. pestis in vivo (42, 43, 60–62), there is little information to
explain the architecture and rapid expansion of neutrophil-rich
lesions that are the pathological hallmark of pneumonic plague.
We hypothesized that Y. pestis directly alters the ability of neutro-
phils to progress through their cellular life cycle, leading to a fail-
ure of clearance from the lungs. This lack of clearance could then
lead to development of the continually expanding inflammatory
lesions, causing significant pulmonary damage. In this work, we
have described a novel approach to examining bacterial pathogen-
esis, using laser capture microdissection (LCM) to dissect unique
spatial phenotypes of tissue damage during infection in vivo that
cannot be studied in vitro.
LCM was first described in 1996 (63) and is sophisticated
enough to allow for DNA, RNA, and protein extraction at the
single-cell level (64). Its use in the field of microbial pathogenesis,
however, has rarely been exploited and has mainly been limited to
plant pathogens (65–69) or in vitro studies (70). In the work pre-
sented here, we show that RNA-seq analysis after LCM is a viable
technique to study host-pathogen interactions during infection.
Furthermore, we can glean information about disease progression
by spatially dissecting regions of inflammation and damage in vivo
that could not be obtained through in vitro studies alone. In the
future, it will be beneficial to be able to perform dual RNA-seq to
obtain both the host and bacterial transcriptomes simultaneously.
The formation of lung lesions during pneumonic plague dis-
ease is well documented in several animal models (41, 71–77). In
this study, we present the first analysis of how these lung lesions
develop and persist during pneumonic plague. Further, we probe
the transcriptomes of host cells in the periphery and center of
these lesions in an effort to better understand this complex mi-
croenvironment. The resulting data indicated that within the lung
lesions, there are spatially defined differences in transcriptional
gene expression. Due to the high concentration of Y. pestis-tar-
geted neutrophils within the lesions (42, 43), we were most inter-
ested in dissecting out neutrophil-specific transcriptional re-
sponses. When performing LCM, nonneutrophil RNA would also
be isolated and complicate the neutrophil-specific analysis we
were seeking. To abrogate this, we isolated BM-PMNs from
mock-infected and Y. pestis-infected mice at 48 hpi to generate a
list of genes we could identify as neutrophil-regulated responses to
Y. pestis infection. By this time during infection, Y. pestis has dis-
seminated into the bloodstream (41) and can even be detected in
the bone marrow (78). We anticipated that any BM-PMN genes
responsive to Y. pestis infection might also be identified in neutro-
phils in the lesion comparison. Analyzing the lesion periphery and
lesion center gave us an unbiased list of differentially expressed
genes between these two regions in any cell type present. Matching
differentially expressed genes from the lesion periphery/center
comparison to the same genes in the BM-PMN comparison re-
sulted in a set of 224 genes we identified as likely neutrophil-
specific transcriptional responses to Y. pestis infection. Using the
BM-PMN list gave us confidence that the 224 genes identified in
both comparisons are indicating a significant alteration in neutro-
phil gene expression between the lesion periphery and center, as
opposed to contaminating monocytic infiltrate or lung epithe-
lium.
In addition to analyzing differential expression between re-
gions of lung lesions, we wanted to test the hypothesis that lesions
develop from small initiating foci and continue expanding out-
ward throughout the course of infection. Alternatively, neutro-
phils could be infiltrating randomly into the lesion space. To ex-
amine this, the RNA-seq data were analyzed based on defined lists
of genes involved in general cell migration and leukocyte-specific
migration compared to the entire transcriptome. The density dis-
tribution of the ratios of genes in each list was analyzed comparing
the lesion periphery to the lesion center. This distribution was
then compared to the same distribution from the entire transcrip-
tome. This statistical comparison helped evaluate if transcription
of genes in each of the lists was being skewed compared to the
entire transcriptome. We observed a statistically significant shift
in the log ratio in the leukocyte migration gene set, indicating
decreased transcription in the center of lung lesions; in contrast,
no shift was observed for genes involved in general cell migration.
This implies that neutrophils in the center of lesions were re-
cruited earlier during infection, and these cells subsequently de-
creased transcription of genes such as those encoding cytokine
and cell-cell adhesion receptors that are necessary for chemotaxis
and lung infiltration (see Table S2 in the supplemental material).
FIG 7 TUNEL staining of infected mouse lung sections. Shown are represen-
tative composite images of lung lesions (48 hpi) stained for damaged DNA
using TUNEL (green) and total DNA using DAPI (blue). TUNEL staining,
generally indicative of apoptosis, was primarily restricted to lung lesions dur-
ing Y. pestis infection. More apoptosis was evident in the lung lesions of mice
infected with the yopM mutant than in those infected with wild-type Y. pestis.
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We also postulated that the lesions continue to expand over
time as a result of Y. pestis-mediated alteration of neutrophil ap-
optosis and survival. The apoptotic pathway gene list was analyzed
as described above. A significant shift in the log ratio distribution
of the apoptosis gene set suggested that these pathways were
downregulated in the center of lesions compared to the periphery.
This list of apoptosis-related genes contains both pro- and anti-
apoptotic genes that need to be analyzed to determine which cat-
egory of genes was being affected. Analysis of the RNA-seq data at
the pathway level with the Ingenuity Pathways Analysis “apoptosis
signaling” pathway (Qiagen) allowed for visualization of how the
altered genes were affecting apoptosis (pro- or anti-). We could
also observe how small changes in expression of pathway-related
genes may escalate into greater effects downstream in the pathway.
Individual genes in pathways did not always show discrete statis-
tically significant differences (P  0.05) between areas of the le-
sion but suggested overall changes when compiled with other gene
alterations. For example, caspases-8 and -9 both had “nonsignifi-
cant” P values (0.5 but 0.05). Looking more closely at where
these caspases intersect in apoptosis signaling pathways, one can
see how a transcriptional decrease in caspase-8 can prevent the
activation of BID to tBID, ultimately preventing the release of
proteins allowing for downstream caspase activation. Both
caspases-8 and -9 are important for direct cleavage of caspase-3,
the converging point of both the extrinsic and intrinsic apoptosis
pathways (79). The decrease in transcription of both of these ini-
tiator caspases is an additional downstream hindrance to apopto-
sis (see Fig. S2 in the supplemental material).
We next sought to confirm that apoptosis is inhibited during
Y. pestis infection in vitro and in vivo and also identify the bacterial
factor or factors that are responsible for this phenotype. We there-
fore inoculated primary human neutrophils with fully virulent
Y. pestis, as well as a repertoire of mutant strains lacking key
virulence-related genes for a more detailed analysis. Prior to inoc-
ulation, Y. pestis was grown at 37°C and was not preopsonized to
most closely mimic conditions during pneumonic plague disease
(41). It has previously been observed that the pCD1 virulence
plasmid of Y. pestis is necessary to inhibit neutrophil production
of reactive oxygen species and decrease neutrophil apoptosis (50).
Although we initially began evaluating apoptosis and death of
neutrophils, we found that, despite an obvious loss of viable neu-
trophils, annexin V staining was not consistently different by
24 hpi. While neutrophils express phosphatidylserine as a marker
of apoptosis, they continue to progress through apoptosis and are
no longer detectable by flow cytometry at later time points. Thus,
examination of a singular time point only visualizes cells that are
currently apoptotic and fails to capture those that have already
gone through apoptosis. We therefore changed our readout to
detect surviving “healthy neutrophils” by subtracting the apopto-
tic neutrophils (annexin V), dead neutrophils (PI), and neu-
trophils that became undetectable by flow cytometry due to turn-
over (subtracting neutrophils at 24 hpi from total starting
neutrophils) from the starting number of neutrophils. We have
shown with this assay that Y. pestis leads to increased survival of
primary human neutrophils and that the T3SS effector YopM is
necessary for this phenotype. This is the first direct evidence that a
single Y. pestis gene is able to extend the survival of neutrophils.
After testing for the known YopM functions of RSK activation
and caspase-1 inhibition, we were unable to confirm that either of
these functions had any effect on neutrophil survival in vitro. We
hypothesize that, similar to YopJ/P (50), YopM has a unique func-
tion in neutrophils that differs from what is observed in macro-
phages. Among the six T3SS effectors that are encoded on the
pCD1 plasmid, only YopM has no known enzymatic function.
Rather, YopM has been shown to have protein-protein binding
functions (80). It was initially shown to bind -thrombin (81) and
subsequently 1-antitrypsin (82), although neither of these bind-
ing functions is thought to contribute to Y. pestis virulence (81).
YopM was later shown to bind p90 ribosomal S6 kinase (RSK) and
protein kinase N1 (PKN) isoforms (27). The C-terminal end of
YopM binds phosphorylated RSK (83), inhibiting dephosphory-
lation and prolonging its kinase activity (55). YopM binding to
RSK and PKN also facilitates activated RSK to phosphorylate PKN
and activate its kinase activity (27). The RSK and PKN binding
domains of YopM are required for interleukin-10 (IL-10) produc-
tion during a Y. pseudotuberculosis intravenous infection (84) and
result in attenuation of virulence (85). More recently it has been
shown that YopM can also bind both active caspase-1 (56) and
IQGAP1 (57), depending on the isoform of YopM being tested.
Both of these binding activities lead to an inhibition of inflam-
masome assembly and impede pyroptosis in macrophages. Other
studies have shown the effects of YopM on bubonic plague and
systemic infection through cytokine analysis and organ-specific
cell composition of lesions (86–89), but this is the first study to
suggest a function of YopM during pneumonic plague as well as its
ability to promote neutrophil survival.
The influence of YopM on apoptosis of neutrophils has been
previously studied in systemic infection by a pgm-negative strain
of Y. pestis and appears to be organ specific (89). Our work focuses
on neutrophils and pathology in the lung during infection with a
fully virulent Y. pestis strain. We demonstrate the importance of
YopM for neutrophil survival in vitro as well as for neutrophil
integrity and reduction of apoptosis in vivo, as demonstrated by
lesion histopathology and TUNEL staining. Linking the in vitro
phenotype of increased neutrophil survival to apoptosis in vivo
further validates the LCM/RNA-seq conclusion that the apoptosis
pathway is inhibited in the center of lung lesions compared to the
periphery. Along with observing cells that lacked a discernible
nucleus, we detected increased, diffuse TUNEL staining after in-
fection with the yopM mutant strain. This physiology and diffuse
damaged DNA staining could suggest the formation of neutrophil
extracellular traps (NETs) within the lung lesions (90). Further
investigation of the formation of NETs after infection with a
yopM mutant strain of Y. pestis could elucidate the specific effect
that YopM is having on neutrophils.
In summary, we introduced a unique application of LCM tech-
nology to examine directly the spatially distinct microenviron-
ments resulting from host-pathogen interactions during primary
pneumonic plague. As a result, we were able to show that Y. pestis
modulates neutrophil survival in vivo in a YopM-dependent man-
ner, interfering with progression through apoptosis. Based on the
healthy appearance of the neutrophils by histology and TUNEL
analysis during Y. pestis infection, it is possible that YopM is pre-
venting the degranulation of neutrophils or inhibiting the initia-
tion of NET formation. Hindering either of these functions would
ultimately result in neutrophils that are not working efficiently to
clear the infection. The active process of Y. pestis inhibiting neu-
trophil function consequently leads to a lack of neutrophil death
and immune cell-mediated bacterial clearance, contributing to
lesion formation in the lung. Further definition and characteriza-
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tion of mediators of the dramatic pulmonary inflammation that
occurs during pneumonic plague will help in understanding the
lethality of this disease and may contribute to our understanding
of severe pulmonary infection with other respiratory pathogens.
MATERIALS AND METHODS
All reagents were obtained from Sigma-Aldrich unless otherwise noted.
Ethics statement. The use of live vertebrate animals was performed in
accordance with the Public Health Service Policy on Humane Care and Use
of Laboratory Animals, the Amended Animal Welfare Act of 1985, and the
regulations of the United States Department of Agriculture (USDA), All
animal studies were approved by the University of North Carolina at
Chapel Hill Office of Animal Care and Use, protocols 12-028.0 and 15-
022.0.
Bacterial strains and culture conditions. The fully virulent Yersinia
pestis strain CO92 and the plasmid-cured strain (pCD1) were obtained
from the U.S. Army, Ft. Detrick, MD. The presence or absence of pCD1
and the pgm locus was confirmed by PCR for each strain before use. The
construction of the pla and yopH Y. pestis strains has been described
previously (10, 20). Yop deletion strains (yopE, -J, -M, -O, and -T) were
constructed using a lambda red recombination system as described pre-
viously (20). The yopM gene was complemented back into its native site
on the pCD1 plasmid using the pSR47S recombination method as previ-
ously described (22, 24). The Escherichia coli strain pir116 was used in the
in vitro assays.
Strains were grown on brain heart infusion (BHI) agar (Difco Labo-
ratories) at 26°C for 2 days. For infections, liquid cultures of Y. pestis CO92
were grown in BHI broth for 6 to 12 h at 26°C. The cultures were then
diluted to an optical density at 620 nm (OD620) of 0.05 to 0.1 in BHI
supplemented with 2.5 mM CaCl2 and grown for 12 to 16 h at 37°C with
constant shaking.
Animals and infections. Six- to 8-week-old female C57BL/6J mice
were obtained from Jackson Laboratories. Mice were provided with food
and water ad libitum and maintained at 25°C and 15% humidity with
alternating 12-h periods of light and dark. For animal infections, groups
of 3 to 10 mice were lightly anesthetized with ketamine/xylazine and in-
oculated intranasally with a lethal dose of 104 CFU suspended in 20 l
phosphate-buffered saline (PBS). The number of actual CFU inoculated
was determined by plating serial dilutions of the inoculum on BHI. Mor-
ibund animals were euthanized with an overdose of sodium pentobarbi-
tal. For determination of bacterial burden, lungs were removed at the
indicated times and homogenized in PBS using a Dremel tissue homoge-
nizer. Serial dilutions of each organ homogenate were plated on BHI agar
and reported as CFU per lung.
Isolation of primary human neutrophils and in vitro assays. Human
blood samples were obtained anonymously from consenting donors
through the UNC Center for AIDS Research Virology Core Laboratory by
common venipuncture according to IRB protocols 96-0859 and 08-0328.
Blood was mixed with equal parts of a 3% dextran in 0.9% saline solution
at room temperature for erythrocyte sedimentation. The top serum layer
was removed and centrifuged at 250 	 g at 4°C for 10 min, and the
supernatant was removed. The pellet was resuspended in 0.9% saline and
underlaid with Ficoll-Paque Plus (GE Healthcare). The gradient was cen-
trifuged at 400 	 g at 26°C for 40 min, and both gradient layers were
removed. To remove the remaining erythrocytes, the pellet was resus-
pended in 0.2% saline for 1 min. An equal volume of 1.6% saline was
added, and the suspension was centrifuged at 250 	 g at 4°C for 6 min.
This erythrocyte wash was repeated, and the final pellet was resuspended
in cold PBS. Neutrophils were enumerated using a hemocytometer.
For in vitro assays, 12-well cell culture plates (Costar) were preincu-
bated with fetal bovine serum (FBS) for 1 h at 37°C. FBS was removed, and
the wells were washed three times with PBS. Wells were plated with ~106
freshly isolated neutrophils suspended in modified RPMI medium (RPMI
1640 without phenol red and HEPES and with L-glutamine [Gibco] buff-
ered to pH 7.2 with 0.25 mM HEPES), and each well was supplemented
with 5% FBS (HyClone), 2.0 mM L-glutamine (CellGro), and 2.5 mM
CaCl2. The cells were then inoculated with various strains of Y. pestis or
treated with chemical inhibitors for 24 h at 37°C with 5% CO2. The chem-
ical inhibitors BI-D1870 (Cayman Chemical Co.) and Z-YVAD-FKM
(BioVision) were used at various concentrations to inhibit the kinase ac-
tivity of RSK isoforms and inhibit the active site of caspase-1, respectively.
Tissue preparation, laser capture microdissection, and RNA isola-
tion. All solutions are either RNase free or have been treated with dieth-
ylpyrocarbonate (DEPC). Lungs were inflated via tracheal cannulation
with RNAlater (Ambion) and incubated for 30 min. Lungs were then fully
inflated with 4% fresh paraformaldehyde and incubated for 2 h for fixa-
tion and removal from the biosafety level 3 (BSL3) laboratory. Lungs were
placed in phosphate buffer (pH 7.4) with 30% sucrose and 20% OCT
compound (Tissue-Tek) for 3 h with intermittent inverting. Lungs were
removed, covered in OCT for 10 min, frozen on dry ice, and stored at
80°C.
Lungs were sectioned into 20-m slices using a Leica-1850 cryostat
and adhered to 1.0-mm PEN membrane slides (Zeiss). To remove OCT
medium from sections, slides were dipped in 100% ethanol and allowed to
dry, incubated in DEPC-treated water for 3 to 5 min, and then dipped into
increasing concentrations of ethanol (70, 95, and 100%) and allowed to
fully dry.
Slides were then loaded onto a Zeiss Palm laser capture microdissec-
tion (LCM) system, and a 4	 objective was used to observe lung lesions.
Opaque adhesive cap Eppendorf tubes were loaded and positioned di-
rectly over the slides. The desired sections of each lung lesion were traced,
cut by a laser, and laser pulse catapulted into the resin preservative in the
top of the adhesive cap tubes. The tubes containing isolated lesion pieces
were stored at 80°C prior to RNA isolation. Total RNA was isolated
from the LCM-extracted lesion pieces using an RNeasy FFPE (formalin-
fixed, paraffin-embedded) kit (Qiagen) as per the manufacturer’s instruc-
tions, with the exception of a 3-h incubation at 56°C after the addition of
proteinase K.
For bone marrow neutrophil isolation, femurs of C57BL/6J mice were
collected and flushed with cold PBS to extract marrow. Marrow cells were
disaggregated by repetitive passes through an 18-gauge needle. Bone mar-
row neutrophils (BM-PMNs) were then isolated using a MACS neutro-
phil isolation kit (Miltenyi Biotec) per the manufacturer’s instructions.
The final volume of BM-PMNs was resuspended in TRIzol reagent (Am-
bion), and total RNA was isolated per the manufacturer’s instructions.
RNA-seq library preparation and analysis. Total RNA was sent for
library preparation and sequencing at the High-Throughput Sequencing
Facility at the University of North Carolina at Chapel Hill. Briefly, a Qubit
RNA assay kit for use with a Qubit fluorometer was used to quantify the
total RNA concentration of each sample. Both eukaryotic RNA and pro-
karyotic rRNA were then removed from the samples using an Epidemiol-
ogy Ribo-Zero Magnetic Gold kit (Epicentre). Complementary DNA was
generated using a SMARTer Universal low-input RNA kit (Clontech)
followed by RNA-seq library sequencing template preparation using a
Clontech low-input library prep kit (Clontech). The library was prepared
and run on a MiSeq sequencer (Illumina) to test the quality of the library.
After library verification, samples were diluted and bar coded for paired
end amplification and clustered (TruSeq SBS kit v2 [200 cycles] and
TruSeq PE Cluster kit v2 [Illumina]) using a cBot (Illumina) for running
on a HiSeq 2000 system (Illumina). Quality control steps throughout the
RNAseq library preparation were performed using a DNA 12-K analysis
kit (Experion) or a LabChipGX HT DNA LabChip kit (Caliper). All MiSeq
and HiSeq kits used the v2 chemistry.
Purity-filtered reads were aligned to the Mus musculus reference ge-
nome (mm9) using MapSplice (91). The alignment profile was summa-
rized by Picard Tools v1.64 (Broad Institute). Aligned reads were sorted
and indexed using SAMtools (92), translated to transcriptome coordi-
nates, and filtered for indels, large inserts, and zero mapping quality using
UBU v1.0. Transcript abundance estimates for each sample were per-
formed using an expectation-maximization algorithm implemented in
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RSEM (93) based on the UCSC knownGene definitions. Raw counts were
normalized to the upper quartile (94). Log-transformed normalized gene
expression estimates were assessed for differential expression using Stu-
dent’s t test, and these results were filtered to highlight genes achieving P
values of 0.05 in both comparisons (BM-PMN and lung lesions). Clus-
ter analysis was performed to assess the patterns of differential expres-
sion (hierarchical clustering based on complete linkage and a Pearson
correlation) for several defined gene sets testing for differential activity
between the conditions. The gene set test performed a Wilcoxon rank-
sum test of the log fold change estimates between genes in a set and
those in the entire transcriptome where there were greater than three
gene reads. Gene set results were visualized using density plots in R
(version 3.1.1).
Harvesting and staining of neutrophils for flow cytometry. Neutro-
phils were resuspended in wells by repetitive pipetting, collected into Ep-
pendorf tubes, and spun for 2 min at 1,000 	 g. Cells were washed in 2%
FBS in PBS (flow buffer) and pelleted by spinning 2 min at 1,000 	 g. Cells
were resuspended in antibody staining solution (flow buffer plus the de-
sired conjugated antibodies at a 1:200 concentration: CD11b-
phyoerythrin [clone M1/70.15; Invitrogen] and Ly6G-phycoerythrin-Cy7
[clone 1A8; BD Bioscience]) on ice for 30 min. Cells were then stained for
the apoptotic marker phosphatidylserine using annexin V-fluorescein
isothiocyanate (FITC) and for cell death using propidium iodide (PI)
(annexin V apoptosis detection kit FITC; Affymetrix) as per the man-
ufacturer’s instructions. A Guava easyCyte 5HT flow cytometer (EMD
Millipore) was used to detect cell staining in a 96-well plate format.
Flow cytometry results were analyzed using InCyte software (EMD
Millipore) and analyzed in Microsoft Excel, and graphs were generated
using GraphPad Prism.
Western blotting. Pellets of primary human neutrophils were lysed in
equal amounts of loading buffer and heated at 80°C prior to equal vol-
umes of lysate being resolved on 10% SDS-PAGE gels. Proteins were
transferred onto nitrocellulose membrane and blocked with 5% nonfat
dry milk in 1	 Tris-buffered saline (TBS)– 0.1% Tween 20. Membranes
were incubated with primary antibody overnight at 4°C. The following
day, membranes were incubated with secondary antibody conjugated to
horseradish peroxidase (HRP) for 1 h at room temperature. Membranes
were incubated and developed using Pico West chemiluminescent reagent
(Thermo). The primary antibodies used were phospho-S6 (S235/S236)
(Cell Signaling) and actin (Santa Cruz), and the secondary antibodies
used were HRP-conjugated anti-rabbit (Cell Signaling) and anti-goat
(Santa Cruz).
HRP-conjugated anti-rabbit, anti-mouse, anti-rat (Cell Signaling),
and anti-goat (Santa Cruz) secondary antibodies were used. Normal
rabbit IgG (Santa Cruz; sc-2027) and protein A beads (Santa Cruz;
sc-2003) were used for preclearing immunoprecipitation samples.
Histopathology and TUNEL staining. Groups of three mice were
inoculated intranasally as described above, and lungs were inflated
with 10% neutral buffered formalin via tracheal cannulation and then
removed and incubated in 10% formalin for a minimum of 24 h. Lungs
were immersed in 70% EtOH, and embedded in paraffin. Five-
micrometer lung sections were adhered to glass slides and stained with
hematoxylin and eosin for examination, and a coverslip was added.
A TUNEL Apo-Green detection kit (Biotool) was used to detect
damaged DNA indicative of apoptosis. Stained slides were mounted
with SlowFade Gold with 4=,6-diamidino-2-phenylindole (DAPI) (In-
vitrogen), and coverslips were added prior to imaging with an Olym-
pus BX60 fluorescence microscope and iVision software v4.0.0
(BioVision Technologies). All images were imported into Adobe Pho-
toshop to merge color channels. Input levels were then uniformly
adjusted for images from the same staining experiment for publication
purposes.
Microarray data accession number. The raw RNA-seq data are
available in the NCBI repository under series record no. GSE70819.
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